Oura adds birth‑control, menopause tracking

Smart rings usually promise generic wellness — sleep, readiness, recovery, stress. But hormones can scramble all of those signals, and most wearables have treated that as background noise. That gap is what Oura is trying to close now. On May 1, the company said it is adding two new women’s-health features: one for people using hormonal birth control, and one for people navigating perimenopause and menopause, with the U.S. rollout starting May 6 for members using Gen3 and Oura Ring 4. ### What exactly is new? The first addition plugs hormonal birth control directly into Cycle Insights. Instead of assuming every user has a natural ovulation-driven cycle, Oura now lets members choose a specific contraceptive method and then view their biometric trends with that context in mind. The second addition is Menopause Insights, which is built to help users make sense of symptoms and how those symptoms line up with sleep, resilience, and recovery patterns over time. ### Why is birth control a hard problem for wearables? Most cycle-tracking features depend on a natural temperature rhythm tied to ovulation. Hormonal contraception often suppresses ovulation, so the old logic breaks. Oura’s own help materials had basically said that classic cycle phases and fertile-window views were not relevant for people on hormonal contraception, even if they could still log bleeding and symptoms. This updated, stripped-down version of the old one. ### What does the birth-control feature actually do? Oura says members can select from a range of hormonal methods — including pills, patches, IUDs, and implants — and then use symptom logging, bleeding tracking, and Oura Advisor prompts to understand what looks typical for them. The company is framing this less as contraception management and more as context: why sleep changed, why temperature changed. Oura is also adding a U.S. partnership with Twentyeight Health so members can connect with a licensed provider in the app and, if appropriate, get a prescription. ### What is Menopause Insights? This is the more ambitious part. Oura says the feature centers on a Menopause Impact Scale, or MIS, a questionnaire it developed to measure how 22 symptoms affect daily functioning and quality of life. The point is not just to hand back a score. Oura says it combines those answers with longitudinal biometric data to explain results in a more personalized way, which is meant to help users see patterns instead of isolated bad nights. ### Didn’t Oura already have something for perimenopause? Sort of. Oura had already rolled out Perimenopause Check-In and other women’s-health features, including Period Prediction, Cycle Insights, Fertile Window, Pregnancy Insights, and its Natural Cycles integration. But those tools were split across fertility, pregnancy, and symptom check-ins. This update pulls the company further into full-lifespan hormone tracking — from health, mostly as cycle prediction. ### Is this medical care? Not really — and that distinction matters. Oura is still a consumer wearable company, not a diagnostic platform. Its own women’s-health materials emphasize guidance, education, and pattern recognition rather than clinical decision-making. The ring can help surface trends worth discussing with a clinician, but it is not replacing hormone tests, menopause care, or contraceptive counseling. ### Why does this matter beyond Oura? Because it shows where wearables are going. Oura is betting that the next step is not just more sensors, but better interpretation of the same signals for groups that older models handled badly. Last week it also introduced a custom women’s-health AI model for Oura Advisor, which fits the same strategy — make the data feel less generic and more physiologically specific. Oura is trying to turn hormone-related “noise” into usable context. If it works, the ring becomes less of a sleep gadget and more of a body-state translator for people whose metrics change with birth control or menopause.